Código QR (código de barras bidimensional)

Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US

Introduction: This study evaluated the cost-effectiveness of atezolizumab + chemotherapy vs. chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC) in the United States (US).Methods: The three health states partitioned survival (PS) model was used over the lifetime. E...

ver descrição completa

Na minha lista:
Principais autores: Yingcheng Wang, Mingjun Rui, Lan Yang, Xintian Wang, Ye Shang, Aixia Ma, Hongchao Li
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021-04-01
coleção:Frontiers in Public Health
Assuntos:
small-cell lung cancer
cost-effectiveness
atezolizumab
chemotherapy
extensive stage
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fpubh.2021.650392/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados